Published March 1994 | Version v1
Journal article

Single photon emission computed tomography with [99Tc]-HM-PAO and [123I]-IBZM in Alzheimer's disease and dementia of frontal type

  • 1. Alzheimer's Disease Care Unit, Ist. S. Cuore-FBF, Brescia (Italy)
  • 2. Neurology Clinic, University Padua, Padua (Italy)
  • 3. Nuclear Medicine, Castelfranco Veneto Hospital, Treviso (Italy)

Description

Dementia of frontal type (DFT) is a fairly common degenerative disease distinct from Alzheimer's disease (AD), whose reportedly distinctive instrumental feature is frontal lobe hypoperfusion on SPECT. We evaluated the cortical dopaminergic system in 6AD, 5 DFT, and 6 control subjects with SPECT and both [99Tc]-HM-PAO, a perfusion tracer, and [123I]-IBZM, a D2 postsynaptic ligand. Both in AD and DFT patients, [99Tc]-HM-PAO SPECT showed a relative frontal hypoperfusion. On the contrary, [123I]-IBZM SPECT showed significantly reduced ligand uptake in superior frontal regions of DFT (0.89 ± 0.08 relative to control subjects) as compared to AD patients (0.97 ± 0.02; difference of means: 0.08, 95% confidence Interval 0.004 to 0.156; p = 0.041). Results suggest more marked involvement of the frontal cortical dopaminergic system in DFT than in AD patients. (au) (24 refs.)

Additional details

Additional titles

Subtitle (English)
Preliminary results

Publishing Information

Journal Title
Acta Neurologica Scandinavica
Journal Volume
89
Journal Page Range
p. 199-203.
ISSN
0001-6314
CODEN
ANRSAS